» Articles » PMID: 16554397

Reduction in Cortisol After Smoking Cessation Among Users of Nicotine Patches

Overview
Journal Psychosom Med
Specialty Psychiatry
Date 2006 Mar 24
PMID 16554397
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Cortisol has been shown to decline after stopping smoking and this decline has been associated with smoking relapse and with reports of increased withdrawal severity and distress. We examined whether a decrease in cortisol is evident in smokers trying to quit using nicotine patches and whether cortisol is related to withdrawal symptoms, smoking urges, subjective stress, nicotine dependence, and smoking relapse.

Methods: Among 112 smokers trying to quit using 15-mg patches, salivary cortisol and reports of stress, withdrawal, and urges were measured before quitting smoking and up to 6 weeks of abstinence among abstinent smokers using 15-mg nicotine patches. Thirty participants both remained abstinent and provided cortisol samples at all measurement times.

Results: Relative to preabstinence, there was a significant decline in cortisol after abstinence of 1 day, and after 1, 2, and 6 weeks (p < .05). The decline in cortisol on the first day of abstinence was positively associated with reported cigarette consumption (p < .01) and tended (nonsignificant) to be associated with smoking relapse at 6 weeks (p = .07). A lower absolute level of cortisol, but not the change in cortisol, on the first day of abstinence was significantly associated with increased reports of urges, withdrawal symptoms, and stress (p < .05), independently of reported cigarette consumption.

Conclusions: Smokers using 15-mg nicotine patches are likely to experience a decline in cortisol on stopping smoking. This decline is likely to be greater among heavier smokers and may predict relapse to smoking. Those with lower cortisol after cessation may experience increased withdrawal symptoms, urges to smoke, and subjective stress.

Citing Articles

Targeting GLP-1 receptors to reduce nicotine use disorder: Preclinical and clinical evidence.

Herman R, Schmidt H Physiol Behav. 2024; 281:114565.

PMID: 38663460 PMC: 11128349. DOI: 10.1016/j.physbeh.2024.114565.


Inhibitory control failures and blunted cortisol response to psychosocial stress in amphetamine consumers after 6 months of abstinence.

Benitez-Lopez Y, Redolar-Ripoll D, Ruvalcaba-Delgadillo Y, Jauregui-Huerta F J Res Med Sci. 2019; 24:20.

PMID: 31007690 PMC: 6450134. DOI: 10.4103/jrms.JRMS_1148_17.


Circulating orexin changes during withdrawal are associated with nicotine craving and risk for smoking relapse.

alAbsi M, Lemieux A, Hodges J, Allen S Addict Biol. 2018; 24(4):743-753.

PMID: 30117237 PMC: 7263380. DOI: 10.1111/adb.12643.


Influences of the Menstrual Phase on Cortisol Response to Stress in Nicotine Dependent Women: A Preliminary Examination.

Nakajima M, Allen S, alAbsi M Nicotine Tob Res. 2018; 21(5):617-622.

PMID: 29648657 PMC: 6769821. DOI: 10.1093/ntr/nty071.


Differences in mood and cortisol by menstrual phase during acute smoking abstinence: A within-subject comparison.

Carlson S, Allen A, Allen S, alAbsi M Exp Clin Psychopharmacol. 2017; 25(5):338-345.

PMID: 29048182 PMC: 5687826. DOI: 10.1037/pha0000142.